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Abstract: Hepatocyte nuclear factor 4a (HNF4a) is essential for liver
development and hepatocyte function. Here, we show that transient
inhibition of HNF4a initiates hepatocellular transformation through
a microRNA-inﬂammatory feedback loop circuit consisting of miR-
124, IL6R, STAT3, miR-24, and miR-629. Moreover, we show that,
once this circuit is activated, it maintains suppression of HNF4a
and sustains oncogenesis. Systemic administration of miR-124,
which modulates inﬂammatory signaling, prevents and suppresses
hepatocellular carcinogenesis by inducing tumor-speciﬁc apoptosis
without toxic side effects. As we also show that this HNF4a circuit
is perturbed in human hepatocellular carcinomas, our data raise
the possibility that manipulation of this microRNA feedback-inﬂam-
matory loop has therapeutic potential for treating liver cancer.
 2012 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.
Hepatocellular carcinoma (HCC) is the most frequent primary
tumor of the liver and a leading cause of cancer-related death.
This tumor stems from terminally differentiated hepatocytes, or
in some cases from resident hepatic progenitor cells. The multi-
step process of HCC development is initiated by various risk fac-
tors, including chronic infection with hepatitis viruses, alcohol,
aﬂatoxin B(1), diabetes and obesity. Whatever the etiology,
tumorigenesis invariably proceeds through inﬂammation, liver
damage and repeated cycles of apoptosis and regeneration, lead-
ing to the accumulation of genetic and epigenetic alterations [1]
(Fig. 1).Journal of Hepatology 20
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transducers linking liver inﬂammation to HCC have been unrav-
eled. Recent focus on NF-jB has revealed diverse and apparently
opposite functions in hepatic inﬂammation, ﬁbrosis, and HCC
induction. It has been shown that activated IkappaB kinase
(IKK)/NF-jB pathway may play a tumor-promoting role by pro-
tecting tumor cells from death or enhancing their proliferation
[2]. In another model, liver-speciﬁc expression of lymphotoxin
alpha and beta induces liver inﬂammation and HCC. By contrast,
in several studies, deletion of NEMO/IKKc caused systematic hep-
atitis and HCC by inhibiting the antiapoptotic function of NF-jB
[3]. This phenotype could be rescued by hepatocyte-speciﬁc
STAT3 ablation. Moreover, deletion of the MAP3-kinase TGF-
beta-activated kinase 1 (TAK1) in liver parenchymal cells could
block TNF-induced NF-jB activation and caused hepatocyte dys-
plasia and HCC.
Importantly, IL6, a target of NF-jB, activates the STAT3 signal-
ing pathway. This pathway has been implicated in the tumor-
promoting effect of obesity in murine models of liver tumorigen-
esis [4], and it might account for gender disparity in HCC inci-
dence both in humans and mice. Thus, modulation of the
inﬂammatory response by the IL6-STAT3 and NF-jB pathways
contributes to enhance the risk of HCC development in the
injured liver.
While liver inﬂammation and hepatocyte proliferation are
recognized as the driving forces of liver cell transformation,
little is known so far on the role of epigenetic changes in
the stabilization of the cellular transformed phenotype that
gives rise to cancer. An interesting mechanistic model support-
ing the early involvement of epigenetic players has been
recently proposed by the teams of Hadzopoulou-Cladaras and
Lliopoulos [5]. This study started with the observation that
treatment of immortalized hepatic cell lines with siRNAs
against the nuclear hormone receptor HNF4a caused cellular
transformation. HNF4a was previously shown to suppress
HCC development by repressing epithelial–mesenchymal tran-
sition, thereby maintaining the epithelial identity of hepato-
cytes [6]. HNF4a orchestrates a transcription factor network
that controls hepatocyte differentiation and liver morphogene-
sis [7]. At later stages, HNF4a expression is pivotal for the
establishment of liver architecture, zonation and functional
activity. The broad effect of HNF4a on liver functions has been
recently involved in the regulation of cytokine-induced inﬂam-
matory responses.12 vol. 57 j 910–912
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Fig. 1. A regulatory circuitry involving microRNAs and HNF4a and STAT3 transcription factors links inﬂammatory responses to hepatocyte transformation. The
major cells of the liver that are mobilized during chronic hepatitis are represented. The blood vessels (sinusoids) between the hepatocyte plates are delineated by
endothelial cells with a tiny space in-between (the Space of Disse) that is occupied by stellate cells. Kupffer cells are abundant resident macrophages involved in
inﬂammatory responses during liver diseases. Production of proinﬂammatory cytokines and activation of NF-jB lead to enhanced hepatocyte turn-over and deregulated
signaling pathways that trigger hepatocyte transformation and cancer development.
JOURNAL OF HEPATOLOGYIn the study commented here, Hatziapostolou et al. observed
that siRNA-induced inhibition of HNF4a expression persisted
for 2 months, beyond the predicted duration of silencing by
short-lived siRNAs. The hypothesis of a positive feedback loop
was suggested by a previous work of the same team, showing
the predominant role of miRNAs in a regulatory circuitry linking
inﬂammation to breast cancer [8]. The search for miRNAs that
directly target HNF4a led to the identiﬁcation of miR-24 and
miR-629. The ﬁnding that ectopic expression of these two miR-
NAs can transform immortalized hepatocytes as efﬁciently as
the downregulation of HNF4a is probably one of the most strik-
ing observations of this work. Such data evoke the activity of
oncogenic miRNAs (oncomiRs) and highlight the reciprocal regu-
lation of speciﬁc oncomiRs and their tumor suppressor targets.
The second step was the identiﬁcation of a STAT3 binding site
in miR-24 and miR-629 promoters. Binding of STAT3 was vali-
dated by chromatin immunoprecipitation, and IL6-mediated
STAT3 activation was associated with increased expression of
the two miRNAs. Increased STAT3 phosphorylation in cells over-
expressing miR-24 and miR-629 indicated the existence of a posi-
tive feedback loop. The search for miRNAs that could be regulated
by HNF4a and in turn block STAT3 activation resulted in the
identiﬁcation of miR-124 as a direct target of HNF4a. miR-124
was strongly downregulated by inhibition of HNF4a expression
as well as overexpression of miR-24 and miR-629, and reduction
of miR-124 expression was accompanied by induction of STAT3Journal of Hepatology 201activation. The feedback loop was closed by the identiﬁcation of
IL6R as a direct target of miR-124 (Fig. 1). These quite remarkable
data obtained in cell lines were validated in murine HCC models
and by analysis of the expression levels of the different protago-
nists in human HCCs.
The HNF4 inﬂammatory circuit emphasizes the complexity of
miRNA-transcription factor crosstalks in liver inﬂammation and
HCC, as previously outlined in recent studies that pinpointed
miRNAs as co-effectors in hepatic inﬂammatory processes [9].
miR-26 is known to target IL6, and accordingly, low levels of
miR-26 in HCC have been correlated with elevated IL6 expres-
sion, activated NF-jB pathway, and poor patients’ survival [10].
HNF4a controls the expression of miR-122, an abundant liver-
speciﬁc miRNA with dual roles in stimulating hepatitis C virus
translation and in conveying some of the tumor suppressive
effects of HNF4a. Notably, a regulatory circuitry involving miR-
122, C/EBPa, GSK3-b, and IGF-1R has been implicated in liver
carcinogenesis. Moreover, induction of the oncogenic miRNA
miR-155 by proinﬂammatory cytokines and NF-jB has been
implicated in alcoholic liver diseases and at early stages of non-
alcoholic steatohepatitis (NASH) (reviewed in [9]).
The work by Hatziapostolou et al. provides insights into the
ability of transient epigenetic changes to initiate a stable feed-
back loop implicated in the transition between non-transformed
and transformed states. Given the therapeutic potential of
manipulating miRNA expression, a major challenge will be to2 vol. 57 j 910–912 911
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properly integrate these insights into a path to the clinic that will
be exploited in the treatment of patients with HCC.Conﬂict of interest
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